麻豆传媒

I have worked in clinical trials for a number of years, firstly as a Clinical Research Associate for commercial pharma companies and as a trial manager at the NCTU since June 2018.

I am currently working on 2 trials:

FRACTAL:

A phase IIa, randomized, 2-arm parallel-group, placebo-controlled, double-blind, multi-centre trial to evaluate safety, tolerability, anti-inflammatory and cardio- protective effects after intravenous and oral administration of KAND567 in ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention

MiTiGate:

Managing chronic Myalgia Temporomandibular Disorder (M-TMD): a pragmatic randomised controlled trial of Botulinum toxin type A, Lidocaine, and Amitriptyline/Gabapentin, with internal pilot and cost-effectiveness analysis (MiTiGate)

None